These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16238705)

  • 1. New antiepileptic drugs in practice--how do they perform in the real world?
    Sander JW
    Acta Neurol Scand Suppl; 2005; 181():26-9. PubMed ID: 16238705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New antiepileptic drugs in pediatric epilepsy.
    Hwang H; Kim KJ
    Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.
    Arif H; Buchsbaum R; Pierro J; Whalen M; Sims J; Resor SR; Bazil CW; Hirsch LJ
    Arch Neurol; 2010 Apr; 67(4):408-15. PubMed ID: 20385905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
    Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epilepsy in children: the evidence for new antiepileptic drugs.
    Verdru P
    Acta Neurol Scand Suppl; 2005; 181():17-20. PubMed ID: 16238703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
    Patsalos PN; Sander JW
    Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antiepileptic drugs on cognition.
    Aldenkamp AP
    Epilepsia; 2001; 42 Suppl 1():46-9, discussion 50-1. PubMed ID: 11422358
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study.
    Peltola J; Peltola M; Auvinen A; Raitanen J; Fallah M; Keränen T
    Acta Neurol Scand; 2009 Jan; 119(1):55-60. PubMed ID: 18616622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new antiepileptic drugs.
    Macleod S; Appleton RE
    Arch Dis Child Educ Pract Ed; 2007 Dec; 92(6):182-8. PubMed ID: 18032714
    [No Abstract]   [Full Text] [Related]  

  • 12. Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy.
    Carpay JA; Aalbers K; Graveland GA; Engelsman M
    Seizure; 2009 Mar; 18(2):119-23. PubMed ID: 18760635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anticonvulsant drugs.
    Stefan H; Feuerstein TJ
    Pharmacol Ther; 2007 Jan; 113(1):165-83. PubMed ID: 17030393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study.
    Lai EC; Hsieh CY; Su CC; Yang YK; Huang CW; Lin SJ; Setoguchi S
    Medicine (Baltimore); 2016 Aug; 95(35):e4481. PubMed ID: 27583857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical application of newer anti-epileptic drugs].
    Terada K; Inoue Y
    Rinsho Shinkeigaku; 2012; 52(11):1088-90. PubMed ID: 23196525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antiepileptic drugs: comparison of key clinical trials.
    Cramer JA; Fisher R; Ben-Menachem E; French J; Mattson RH
    Epilepsia; 1999 May; 40(5):590-600. PubMed ID: 10386528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
    Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Antiepileptic Drugs on Cognition: Patient Perceived Cognitive Problems of Topiramate versus Levetiracetam in Clinical Practice.
    Bootsma HP; Aldenkamp AP; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsia; 2006; 47 Suppl 2():24-7. PubMed ID: 17105455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
    Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial.
    Bonnett L; Smith CT; Smith D; Williamson P; Chadwick D; Marson AG
    Lancet Neurol; 2012 Apr; 11(4):331-40. PubMed ID: 22377180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.